Gammazza, A.M. et al. 2017. Doxorubicin anti-tumor mechanisms include Hsp60 post-translational modifications leading to the Hsp60/p53 complex dissociation and instauration of replicative senescence. Italian Journal of Anatomy and Embryology. 121, 1 (Oct. 2017), 131.